• Bryan  Sendrowski

    As a member of the Private Transactions team at Deerfield, Bryan joined Deerfield in 2012 and is responsible for the day to day oversight and management of investments in our Private Design Funds. Prior to joining Deerfield, Bryan was Chief Financial Officer of New American Therapeutics, a specialty pharmaceutical company that was funded and facilitated by Deerfield’s Private Design Funds. Bryan has over 10 years of experience in the pharmaceutical industry. Prior to New American Therapeutics, Bryan was Chief Financial Officer at Akrimax Pharmaceuticals and Vice President and Controller of Reliant Pharmaceuticals. He also previously served as a Senior Manager in the financial statement audit practice of KPMG, LLP with responsibility for the management of public and private company audits. Mr. Sendrowski received his B.A. from Pace University and was licensed as a Certified Public Accountant in the state of New Jersey.